id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0093-0010,FDA,FDA-2013-N-0093,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals",Notice,Notice of Approval,2016-12-19T05:00:00Z,2016,12,2016-12-19T05:00:00Z,,2016-12-19T15:47:08Z,2016-30351,0,0,09000064824264d4
FDA-2013-N-0093-0007,FDA,FDA-2013-N-0093,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Evaluation of the
Program for Enhanced Review Transparency and Communication for
New Molecular Entity New Drug Applications and Original Biologics
License Applications in Prescription Drug User Fee Acts",Notice,30 Day Proposed Information Collection,2016-07-21T04:00:00Z,2016,7,2016-07-21T04:00:00Z,2016-08-23T03:59:59Z,2016-08-23T01:02:01Z,2016-17185,0,0,09000064820db4f9